STOCK TITAN

Nrx Pharmaceuticals Stock Price, News & Analysis

NRXPW NASDAQ

Company Description

Nrx Pharmaceuticals (NASDAQ: NRXPW) is a publicly traded company in the Pharmaceutical Preparations sector.

NRXPW stock has declined 96.6% over the past year. Shares last traded at $0.0026.

On a trailing twelve-month basis, Nrx Pharmaceuticals reported revenue of $1.2M with net income of -$28.6M. The company operates at a net profit margin of -2336.5%.

This page provides a comprehensive overview of NRXPW stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

$—
0.00%
0.00
Last updated:
-96.61%
Performance 1 year

Nrx Pharmaceuticals (NRXPW) stock last traded at $0.0026. Over the past 12 months, the stock has lost 96.6%.

NRXPW Rankings

Latest News

No recent news available for NRXPW.

SEC Filings

Nrx Pharmaceuticals has filed 10 recent SEC filings, including 2 Form 4, 2 Form 25-NSE, 2 Form 10-Q, 2 Form SCHEDULE 13G/A. The most recent filing was submitted on May 22, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all NRXPW SEC filings →

Financial Highlights

Nrx Pharmaceuticals generated $1.2M in revenue over the trailing twelve months, retaining a 58.8% gross margin, operating income reached -$16.2M (-1324.4% operating margin), and net income was -$28.6M, reflecting a -2336.5% net profit margin. The company generated -$14.1M in operating cash flow. With a current ratio of 0.31, short-term liquidity bears monitoring.

$1.2M
Revenue (TTM)
-$28.6M
Net Income (TTM)
-$14.1M
Operating Cash Flow

Upcoming Events

Short Interest History

Last 12 Months

Short interest in Nrx Pharmaceuticals (NRXPW) currently stands at 2.2 thousand shares, down 62.3% from the previous reporting period, representing 0.6% of the float. Over the past 12 months, short interest has increased by 53.9%. This relatively low short interest suggests limited bearish sentiment.

Days to Cover History

Last 12 Months

Days to cover for Nrx Pharmaceuticals (NRXPW) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.

NRXPW Company Profile & Sector Positioning

Nrx Pharmaceuticals (NRXPW) operates in the Pharmaceutical Preparations sector and is listed on the NASDAQ.

Frequently Asked Questions

What is the current stock price of Nrx Pharmaceuticals (NRXPW)?

The current stock price of Nrx Pharmaceuticals (NRXPW) is $0.0026 as of May 22, 2026.

What is the revenue (TTM) of Nrx Pharmaceuticals (NRXPW) stock?

The trailing twelve months (TTM) revenue of Nrx Pharmaceuticals (NRXPW) is $1.2M.

What is the net income of Nrx Pharmaceuticals (NRXPW)?

The trailing twelve months (TTM) net income of Nrx Pharmaceuticals (NRXPW) is -$28.6M.

What is the operating cash flow of Nrx Pharmaceuticals (NRXPW)?

The operating cash flow of Nrx Pharmaceuticals (NRXPW) is -$14.1M. Learn about cash flow.

What is the profit margin of Nrx Pharmaceuticals (NRXPW)?

The net profit margin of Nrx Pharmaceuticals (NRXPW) is -2336.5%. Learn about profit margins.

What is the operating margin of Nrx Pharmaceuticals (NRXPW)?

The operating profit margin of Nrx Pharmaceuticals (NRXPW) is -1324.4%. Learn about operating margins.

What is the gross margin of Nrx Pharmaceuticals (NRXPW)?

The gross profit margin of Nrx Pharmaceuticals (NRXPW) is 58.8%. Learn about gross margins.

What is the current ratio of Nrx Pharmaceuticals (NRXPW)?

The current ratio of Nrx Pharmaceuticals (NRXPW) is 0.31, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.

What is the gross profit of Nrx Pharmaceuticals (NRXPW)?

The gross profit of Nrx Pharmaceuticals (NRXPW) is $720K on a trailing twelve months (TTM) basis.

What is the operating income of Nrx Pharmaceuticals (NRXPW)?

The operating income of Nrx Pharmaceuticals (NRXPW) is -$16.2M. Learn about operating income.